Stay updated on 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.

Latest updates to the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe study page now includes sponsor and investigator information, as well as additional links and expanded study content (protocol and statistical plan, imaging plans, eligibility criteria, and related terminology), enriching the contextual information and navigation of the record. This broader set of metadata reflects a more complete and accessible study documentation.SummaryDifference48%

- Check10 days agoChange DetectedThe page now shows Revision: v3.6.5 and the previous Revision: v3.6.4 has been removed. This reflects a version update to the page's content.SummaryDifference0.1%

- Check17 days agoChange DetectedNew related-topic links for 'Multiple myeloma' and 'MedlinePlus Genetics' have been added. They improve navigation and access to disease-related information without altering the study data.SummaryDifference0.2%

- Check24 days agoChange DetectedThe page's revision line was updated from v3.6.3 to v3.6.4, reflecting a new site version.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page no longer shows the condition label 'Multiple myeloma' and removes the 'MedlinePlus Genetics' related topics section. This reduces explicit health-topic labeling and the available related-resource links on the study page, affecting how users interpret the study focus and find background information.SummaryDifference0.2%

- Check46 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 on the page, signaling a page update. This change does not modify the study content or details presented.SummaryDifference0.1%

Stay in the know with updates to 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.